七氟醚
异丙酚
活力测定
麻醉剂
间充质干细胞
骨髓
MTT法
药理学
细胞
移植
医学
化学
麻醉
病理
外科
生物化学
作者
Xue Zhou,Ying-Qin Li,Wen He,Xiao-Yu Yang,Fa-Huan Song,Zhi-Bin Zhou,Ying Tang,Xia Feng,Li-Hua Zhou
出处
期刊:International Journal of Clinical Pharmacology and Therapeutics
[Dustri-Verlag Dr. Karl Feistle]
日期:2013-04-01
被引量:4
摘要
Bone marrow mesenchymal stem cell (BMSC) is a potentially effective vehicle for the cell and gene therapy in clinical disease treatment. We studied whether the most commonly used anesthetic drugs have negative effects on rat BMSCs in vitro.The cultured BMSCs were treated with sevoflurane (in 1.7%, 2.3%, and 3%); propofol (5 μg/ml, 10 μg/ml and 20 μg/ml); or 2.3% sevoflurane plus 10 μg/ml propofol. After 4-hour treatment, the cultured BMSCs were prepared for MTT reduction assays and cell morphology observation.Compared to the controls, the 4-hour sevoflurane exposure resulted in decreased cell viability of BMSCs in a concentration-dependent manner; however, 1.7% sevoflurane did not reduce the cell viability. The 4-hour propofol treatment did not affect the cell viability; but combined usage of 2.3% sevoflurane and 10 μg/ml propofol decreased cell viability. In BMSCs treated with higher concentration of sevoflurane (1.7% and 2.3%) and combined usage of the two anesthetics, the cell became raritas with wizened cytoplasm and had fewer connections to each other of BMSCs. More than 2.3%, or 2.3% sevoflurane plus 10 μg/ ml propofol caused cytotoxicity to BMSCs. However, propofol up to 20 μg/ml did not harm the BMSCs.The study indicates that it is necessary to choose the right anesthesia during the BMSCs transplantation therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI